Stay updated on Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.2 to v3.5.3, indicating a small version update to the study record page. The update does not alter the study details shown to users.
    Difference
    0.0%
    Check dated 2026-04-30T17:55:03.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and revision: v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-16T11:16:12.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Added a Publications entry for the Phase II study article: Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer with Clin Colorectal Cancer citation and DOI. The entry is automatically populated from PubMed.
    Difference
    0.3%
    Check dated 2026-03-18T19:34:35.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T17:20:57.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added system Revision: v3.4.2 and removed the funding notice Revision: v3.4.1. No study data or page content were changed; (To avoid being alerted by small changes, set an alert condition by clicking below.)
    Difference
    0.4%
    Check dated 2026-02-11T05:56:34.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Notice about government funding lapse and NIH Clinical Center status added at the top of the page. Page revision updated to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:46:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.